Cough Medicine Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2027

The global cough medicine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Tobacco use, postnasal drip, asthma, and gastroesophageal reflux disease (GERD) are the most common causes of cough. The major factor for the growth of the market during the forecast period is the increase in the number geriatric population more prone to cough and cold. Additionally, the increasing pollution coupled with the increasing development of R&D activities.

Furthermore, the market is also growing due to the ongoing COVID-19 pandemic. Due to COVID-19 pandemic, there is a surge in the demand for cough medicine as the common cold, cough being the major symptom of the virus. Moreover, the market is also growing owing to new product launches. For instance, in September 2021, Sun Pharmaceutical Industries Ltd. announced the launch of Chericof 12 (Dextromethorphan Hydrobromide 30 mg and Chlorpheniramine Maleate 4 mg). It is a novel formulation in cough management and was launched in India. Hence, the rising demand for cough medicine and new product launches is driving the growth of the market.

To Request a Sample of our Report on Cough Medicine Market: https://www.omrglobal.com/request-sample/cough-medicine-market

Some major players in the market include AstraZeneca plc, GlaxoSmithKline plc, and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in October 2020, GSK Consumer Healthcare announced the launch of Robitussin Naturals. It is the brand's first-ever line of drug-free products that provide relief from the occasional cough.

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

· By Product Type

· By Age Group

· By Distribution Channel

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- AstraZeneca plc, GlaxoSmithKline plc, and Novartis International AG, among others.

(Get 15% Discount on Buying this Report)

A full Report of Cough Medicine Market is Available @ https://www.omrglobal.com/industry-reports/cough-medicine-market

Global Cough Medicine Market Report by Segment

By Product Type

• Expectorants

• Antihistamines

• Decongestants

• Antibiotics

By Age Group

• Pediatric

• Adult

By Distribution Channel

• Retail Pharmacy

• Hospital Pharmacy

• Online Pharmacy

Global Cough Medicine Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.